Assessing Reactive Astrogliosis with

Alzheimer Disease / diagnostic imaging Amyloid beta-Peptides / metabolism Australia Biomarkers Cross-Sectional Studies Female Gliosis Humans Inflammation Male Monoamine Oxidase Quinolines
Alzheimer disease MAO-B amyloid brain imaging reactive astrogliosis tau

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
10 2022
Historique:
received: 22 09 2021
accepted: 14 01 2022
pubmed: 29 1 2022
medline: 6 10 2022
entrez: 28 1 2022
Statut: ppublish

Résumé

A neuroinflammatory reaction in Alzheimer disease (AD) brains involves reactive astrocytes that overexpress monoamine oxidase-B (MAO-B).

Identifiants

DOI: 10.2967/jnumed.121.263255 PMID: 35086892 PMC: PMC9536709
pubmed: 35086892
pii: jnumed.121.263255
doi: 10.2967/jnumed.121.263255
pmc: PMC9536709
doi:

Substances chimiques

Amyloid beta-Peptides 0
Biomarkers 0
Quinolines 0
Monoamine Oxidase EC 1.4.3.4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1560-1569

Informations de copyright

© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Références

Alzheimers Dement. 2015 Jan;11(1):1-15.e1-4
pubmed: 25443857
Alzheimers Dement. 2018 Dec;14(12):1565-1571
pubmed: 30006100
Exp Neurol. 1995 Jun;133(2):225-30
pubmed: 7544290
J Addict Dis. 1998;17(1):23-34
pubmed: 9549600
Neurochem Int. 2011 Jan;58(1):60-8
pubmed: 21075154
Nat Neurosci. 2021 Mar;24(3):312-325
pubmed: 33589835
Neuroimage. 2018 Dec;183:387-393
pubmed: 30130643
Cold Spring Harb Perspect Biol. 2014 Nov 07;7(2):a020420
pubmed: 25380660
Mol Psychiatry. 2021 Oct;26(10):5848-5855
pubmed: 34267329
J Nucl Med. 2016 Aug;57(8):1233-7
pubmed: 26912446
Brain Struct Funct. 2017 Jul;222(5):2017-2029
pubmed: 28280934
IEEE Trans Med Imaging. 1999 Oct;18(10):897-908
pubmed: 10628949
Mol Psychiatry. 2021 Oct;26(10):5833-5847
pubmed: 33888872
Alzheimers Res Ther. 2021 Mar 27;13(1):68
pubmed: 33773595
JAMA Neurol. 2020 Nov 1;77(11):1408-1419
pubmed: 33165511
Neurochem Int. 2019 Sep;128:70-84
pubmed: 30986503
J Nucl Med. 2012 Jan;53(1):37-46
pubmed: 22213821
J Neural Transm Gen Sect. 1995;101(1-3):83-94
pubmed: 8695059
Neurochem Int. 2020 Sep;138:104758
pubmed: 32439533
Trends Mol Med. 2019 Feb;25(2):77-95
pubmed: 30611668
Neurosci Res. 2018 Jan;126:31-38
pubmed: 29054467
Brain. 2018 May 1;141(5):1517-1528
pubmed: 29538647
Curr Neuropharmacol. 2018;16(5):508-518
pubmed: 28730967
Transl Psychiatry. 2021 Jan 11;11(1):27
pubmed: 33431793
Brain. 2019 Jun 1;142(6):1503-1527
pubmed: 31039256
JAMA Psychiatry. 2019 Jun 1;76(6):634-641
pubmed: 30840042
Lancet Neurol. 2013 Apr;12(4):357-67
pubmed: 23477989
Biochem Soc Trans. 2014 Oct;42(5):1316-20
pubmed: 25233409
Arch Neurol. 1999 Mar;56(3):303-8
pubmed: 10190820
EJNMMI Res. 2018 Dec 5;8(1):107
pubmed: 30519791
Neurology. 2020 Apr 7;94(14):e1512-e1524
pubmed: 32188766
Int J Clin Exp Med. 2012;5(2):201-7
pubmed: 22567182
Sci Rep. 2015 Nov 10;5:16404
pubmed: 26553227
Glia. 1993 Jun;8(2):122-32
pubmed: 8406673
Prog Neurobiol. 2016 Sep;144:121-41
pubmed: 26797041
Front Aging Neurosci. 2018 Apr 25;10:114
pubmed: 29922147
Alzheimers Dement. 2015 Feb;11(2):126-38
pubmed: 25130658
Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1686-1691
pubmed: 30635412
Front Cell Neurosci. 2015 Oct 27;9:414
pubmed: 26578880
Front Neurol. 2020 Dec 22;11:598980
pubmed: 33414760
Brain. 2012 Jul;135(Pt 7):2126-39
pubmed: 22628162
Biomed Res Int. 2018 May 14;2018:4160247
pubmed: 29888263
EJNMMI Res. 2018 Jul 30;8(1):71
pubmed: 30062395
Alzheimers Dement. 2017 Mar;13(3):205-216
pubmed: 27697430
Synapse. 2010 Jan;64(1):61-9
pubmed: 19728365
J Nucl Med. 2021 Feb;62(2):253-258
pubmed: 32646880
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
Neurology. 2016 Aug 2;87(5):539-47
pubmed: 27371494
J Neuroinflammation. 2017 Dec 22;14(1):259
pubmed: 29273052
ScientificWorldJournal. 2013;2013:589308
pubmed: 23476143
J Nucl Med. 2022 Oct;63(10):1551-1559
pubmed: 35086898
Neurology. 2004 Mar 23;62(6):925-31
pubmed: 15037694
Neurobiol Aging. 2016 Aug;44:53-61
pubmed: 27318133
Brain Res. 2021 May 1;1758:147291
pubmed: 33516810
Acta Neuropathol Commun. 2018 Jun 11;6(1):50
pubmed: 29891013
Eur J Nucl Med Mol Imaging. 2015 Jun;42(7):1119-32
pubmed: 25893384
Brain. 2016 Mar;139(Pt 3):922-36
pubmed: 26813969

Auteurs

Victor L Villemagne (VL)

Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Victoria, Australia; victor.villemagne@pitt.edu.
Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania.

Ryuichi Harada (R)

Department of Pharmacology, School of Medicine, Tohoku University, Sendai, Japan.
Institute of Development of Aging and Cancer, Tohoku University, Sendai, Japan.

Vincent Doré (V)

Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Victoria, Australia.
CSIRO Health and Biosecurity Flagship: Australian e-Health Research Centre, Melbourne, Victoria, Australia.

Shozo Furumoto (S)

Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan.

Rachel Mulligan (R)

Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Victoria, Australia.

Yukitsuka Kudo (Y)

Institute of Development of Aging and Cancer, Tohoku University, Sendai, Japan.

Samantha Burnham (S)

CSIRO Health and Biosecurity Flagship: Australian e-Health Research Centre, Melbourne, Victoria, Australia.

Natasha Krishnadas (N)

Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Victoria, Australia.

Pierrick Bourgeat (P)

CSIRO: Australian e-Health Research Centre, Brisbane, Queensland, Australia.

Ying Xia (Y)

CSIRO: Australian e-Health Research Centre, Brisbane, Queensland, Australia.

Simon Laws (S)

School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia.

Svetlana Bozinovski (S)

Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Victoria, Australia.

Kun Huang (K)

Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Victoria, Australia.

Milos D Ikonomovic (MD)

Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania.
Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Geriatric Research Education and Clinical Center, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania.

Jürgen Fripp (J)

CSIRO: Australian e-Health Research Centre, Brisbane, Queensland, Australia.

Kazuhiko Yanai (K)

Department of Pharmacology, School of Medicine, Tohoku University, Sendai, Japan.

Nobuyuki Okamura (N)

Division of Pharmacology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.

Christopher C Rowe (CC)

Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Victoria, Australia.
Florey Institute of Neurosciences and Mental Health, University of Melbourne, Melbourne, Victoria, Australia; and.
Australian Dementia Network, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Troubles mentaux › Troubles neurocognitifs › Démence › Maladie d'Alzheimer › Assessing Reactive Astrogliosis with
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Peptides bêta-amyloïdes › Assessing Reactive Astrogliosis with
questionsmedicales.fr › Régions géographiques › Océanie › Australasie › Australie › Assessing Reactive Astrogliosis with
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Assessing Reactive Astrogliosis with
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études transversales › Assessing Reactive Astrogliosis with
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Gliose › Assessing Reactive Astrogliosis with
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Assessing Reactive Astrogliosis with
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Inflammation › Assessing Reactive Astrogliosis with
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Oxidoreductases › Oxidoreductases acting on CH-NH2 group donors › Monoamine oxidase › Assessing Reactive Astrogliosis with
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › Quinoléines › Assessing Reactive Astrogliosis with